19-50293703-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001145809.2(MYH14):​c.5469+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 1,542,138 control chromosomes in the GnomAD database, including 424,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 35484 hom., cov: 33)
Exomes 𝑓: 0.74 ( 389189 hom. )

Consequence

MYH14
NM_001145809.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -4.41

Publications

10 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-50293703-C-T is Benign according to our data. Variant chr19-50293703-C-T is described in ClinVar as Benign. ClinVar VariationId is 257578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.5469+16C>T intron_variant Intron 39 of 42 ENST00000642316.2 NP_001139281.1 Q7Z406-2A1L2Z2B3KWH4
MYH14NM_001077186.2 linkc.5370+16C>T intron_variant Intron 38 of 41 NP_001070654.1 Q7Z406-6B3KWH4
MYH14NM_024729.4 linkc.5346+16C>T intron_variant Intron 37 of 40 NP_079005.3 Q7Z406-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.5469+16C>T intron_variant Intron 39 of 42 NM_001145809.2 ENSP00000493594.1 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.661
AC:
100501
AN:
152014
Hom.:
35464
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.394
Gnomad AMI
AF:
0.646
Gnomad AMR
AF:
0.773
Gnomad ASJ
AF:
0.722
Gnomad EAS
AF:
0.922
Gnomad SAS
AF:
0.779
Gnomad FIN
AF:
0.764
Gnomad MID
AF:
0.722
Gnomad NFE
AF:
0.750
Gnomad OTH
AF:
0.685
GnomAD2 exomes
AF:
0.754
AC:
149415
AN:
198216
AF XY:
0.757
show subpopulations
Gnomad AFR exome
AF:
0.388
Gnomad AMR exome
AF:
0.857
Gnomad ASJ exome
AF:
0.711
Gnomad EAS exome
AF:
0.931
Gnomad FIN exome
AF:
0.768
Gnomad NFE exome
AF:
0.747
Gnomad OTH exome
AF:
0.747
GnomAD4 exome
AF:
0.745
AC:
1035465
AN:
1390006
Hom.:
389189
Cov.:
41
AF XY:
0.746
AC XY:
509743
AN XY:
683016
show subpopulations
African (AFR)
AF:
0.384
AC:
12159
AN:
31626
American (AMR)
AF:
0.846
AC:
29639
AN:
35030
Ashkenazi Jewish (ASJ)
AF:
0.713
AC:
15314
AN:
21474
East Asian (EAS)
AF:
0.910
AC:
35425
AN:
38948
South Asian (SAS)
AF:
0.785
AC:
58582
AN:
74664
European-Finnish (FIN)
AF:
0.766
AC:
38954
AN:
50878
Middle Eastern (MID)
AF:
0.731
AC:
3909
AN:
5348
European-Non Finnish (NFE)
AF:
0.744
AC:
799947
AN:
1074786
Other (OTH)
AF:
0.725
AC:
41536
AN:
57252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
12546
25092
37637
50183
62729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20046
40092
60138
80184
100230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.661
AC:
100560
AN:
152132
Hom.:
35484
Cov.:
33
AF XY:
0.669
AC XY:
49765
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.394
AC:
16345
AN:
41468
American (AMR)
AF:
0.774
AC:
11827
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
2507
AN:
3472
East Asian (EAS)
AF:
0.923
AC:
4782
AN:
5182
South Asian (SAS)
AF:
0.779
AC:
3760
AN:
4824
European-Finnish (FIN)
AF:
0.764
AC:
8085
AN:
10584
Middle Eastern (MID)
AF:
0.718
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
0.750
AC:
51004
AN:
68000
Other (OTH)
AF:
0.688
AC:
1451
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1572
3145
4717
6290
7862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.722
Hom.:
19153
Bravo
AF:
0.651
Asia WGS
AF:
0.838
AC:
2912
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.034
DANN
Benign
0.52
PhyloP100
-4.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3745510; hg19: chr19-50796960; API